Gary is a Senior Associate Director, Clinical Quality Assurance, for Pfizer Global Research and Development in New London, CT. He has a BS in Microbiology from Penn State and an MS in Pharmacology from Temple University. As Global Head of Quality Systems Management, Gary has responsibility for training to assure global auditor competency and coordinating CQA participation in training to other Pfizer colleagues as subject matter experts in GCP, inspection readiness, etc. Gary is also responsible for Global CQA SOPs, review and interpretation of GCP regulations, process improvement, and staff development. He has traveled to a number of developing countries to assess conditions, conduct audits and train country personnel including China, India, South Africa, Costa Rica, Venezuela, and Argentina, and spent several months reorganizing the CQA group in Japan. Prior to joining Pfizer he worked for ICI Pharmaceuticals as GCP Manager, and with FDA as an investigator in Philadelphia District.
Gary is Chairman of the PhRMA Bioresearch Monitoring Committee, which represents industry on GCP/GLP issues including audit report confidentiality, ICH GCP guidelines, and financial disclosure for investigators. Gary was a member of the drafting workgroup on the PhRMA Principles on Conduct of Clinical Trials and Communication of Clinical trial Results, and has taught at PERI Basic and Advanced GCP and Data Management courses. He frequently presents on topics such as FDA Inspectional Findings, Detection and Prevention of Fraud, and Conduct of Research in Developing Markets at internal and external workshops and training sessions.

Return to Faculty Home